Recon: Prasad regains FDA chief medical and scientific officer title; FDA panel to review AI mental health devices
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States